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ORIGINAL ARTICLE
Decreased neutrophil apoptosis in tracheal fluids of
preterm infants at risk of chronic lung disease
J Oei, K Lui, H Wang, R Henry
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Objective: To investigate the hypothesis that preterm infants who are more susceptible to lung damage
have decreased neutrophil apoptosis, and to explore its relation to interleukin 10 (IL10) concentration.
Design: Prospective cohort design.
Patients: One hundred tracheal fluid specimens from 50 week-1 ventilated infants were examined for
IL10 (by enzyme linked immunosorbent assay) and neutrophil apoptosis (by light microscopy).
Results: Neutrophil apoptosis was absent or less than 0.22% (median 0%) in the 11 infants with
chronic lung disease (CLD) (24–31 weeks gestation) during the first 4 days of life. This was significantly
lower than that of the 20 preterm infants without CLD (27–31 weeks gestation; median 0.47%, range
0–1.25%) and 19 term infants (median 0.5%, range 0–2.25%). There was an increase in apoptosis in
infants with CLD (median 0.44%, p = 0.046) during days 5–7. Few infants without CLD were intubated
beyond 4 days. Median apoptosis on days 5–7 was 0.26% and 2.78% for non-CLD preterm and term
infants, but differences were not significant. IL10 concentration in tracheal fluid of infants with CLD was
less than 5 pg/ml. None of the infants with IL10 greater than 5 pg/ml developed CLD. The range of
IL10 concentrations in tracheal fluid from infants without CLD was wide (0–938 pg/ml). There was no
apparent correlation between IL10 levels and percentage neutrophil apoptosis in infants without CLD.
Conclusion: Preterm infants with low levels of IL10 and neutrophil apoptosis may be predisposed to
disordered lung repair. Further studies into the method of disposal of senescent neutrophils within pre-
term lungs are required.
Positive pressure ventilation and oxygen disrupts lungepithelium. An inflammatory response characterised by aneutrophilic influx rapidly occurs.1 2 There is no evidence
that these neutrophils are able to leave the lung and re-enter the
microcirculation after the inflammatory stimulus is resolved.3
Their activity must thus be curtailed, and senescent neutrophils
must be disposed of before healing can occur. Infants who
develop chronic lung disease (CLD) have more alveolar
neutrophils and cytotoxic byproducts such as elastase and leu-
kotriene B4 than infants whose acute lung disease resolves.
4
How neutrophils are cleared from the lungs of premature
infants is unknown. Senescent neutrophils that die by necro-
sis release toxic intracellular substances that may perpetuate
lung damage.5 Apoptosis or programmed cell death, on the
other hand, reduces the inflammatory activity of both
neutrophils and macrophages6 and has been shown to hasten
the resolution of experimental lung injury.3 7 8 The only
endogenous factor known to promote neutrophil apoptosis is
interleukin (IL) 10, an anti-inflammatory cytokine present in
low quantities in the lungs of patients with severe respiratory
disease.9 We hypothesised that premature infants are more at
risk of lung injury because of reduced neutrophil apoptosis
and IL10.
METHODS
Mechanically ventilated infants admitted to the neonatal
intensive care unit of the Royal Hospital for Women were
recruited into our study.We defined CLD in premature infants
as a need for support with supplemental oxygen and/or
mechanical ventilation beyond the postconceptional age of 36
weeks.10 Ventilatory strategies as well as decisions on
treatment with exogenous surfactant and corticosteroids were
determined by individual neonatologists. Our nursery admin-
isters exogenous surfactant (bovine; Survanta; Abbott Phar-
maceuticals) as a rescue treatment in radiologically proven
hyaline membrane disease (HMD) or meconium aspiration
syndrome (MAS). Dexamethasone is prescribed in a tapering
regimen of 4.5 mg/kg over two weeks for acute respiratory
deterioration secondary to evolving CLD. Theophylline is pre-
scribed to infants less than 30 weeks gestation for 12 hours
before extubation to augment the success rate of
extubation.11 This study was approved by the ethics committee
of the South Eastern Sydney Area Health Service.
Tracheal fluid collection
Tracheal fluid was collected at least twice weekly during the
first week of each infant’s life. Collection was timed to
coincide with laboratory availability (Mondays, Wednesdays,
and Fridays) and with routine endotracheal suctioning of
each intubated infant every six to eight hours. Two or more
specimens were thus obtained from each infant depending on
the day of its birth. Tracheal fluid was obtained in a similar
fashion to that of McColm et al12: we instilled 0.5 ml normal
saline into each infant’s endotracheal tube and suctioned the
residue with a 5F suction catheter after two or three ventilator
breaths. Suction catheters were passed to a standardised
length of 0.5–1 cm beyond the tip of each endotracheal tube.
This method of suctioning was well tolerated by even the most
critically unwell infants. Each collection was transported
immediately to our on site laboratory for processing.
Specimens that yielded less than 50 µL lavage fluid were dis-
carded because of a possibility that adjustment of low volume
specimens would result in large assay errors.
Sample processing and analysis of apoptosis
Cells were isolated by centrifugation and resuspension of
tracheal fluid at 200 g for 10 minutes and then counted with
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a haemocytometer. Supernatant was stored at −80°C and
examined in batches for IL8 and IL10. Two or more slides
were made by cytospin preparation of each sample, and the
slides were stained with Diff-Quik (Lab Aids Pty Ltd,
Narrabeen, Australia) and confirmed by agarose gel electro-
phoresis. This procedure involves the fixation of the cell pal-
let obtained immediately after centrifugation of the lavage
material by 70% alcohol. To obtain DNA, the fixed cells were
then treated by lysis and nuclear buffers. Ethidium bromide
staining was used to ascertain if ladder development had
occurred during agarose gel electrophoresis of the extracted
DNA (concentration of agarose gel was 2%; electrophoresis
was performed for 30 minutes using a Gene Power Supply
(Pharmacia GPS 200/400) at 100 V).
Differential cell counts and characteristic changes in
neutrophil apoptosis (chromatin condensation and simplifica-
tion of nuclear structure)6 were assessed by phase contrast
microscopy of 400 cells under oil immersion (fig 1). Even
though the TUNEL (terminal deoxynucleotidyl transferase
mediated dUTP nick end labeling) method is widely used to
identify apoptotic cell fractions in cultured cell preparations,
we used Diff-Quik staining to avoid some of the potential arti-
facts associated with the TUNEL assay—for example, depend-
ence on staining kinetics of the reagent, or on tissue fixation,
or on the extent of proteolysis of the cells.13
Cytokine analysis
IL10 was analysed in batches by enzyme linked imuunosorb-
ent assay (ELISA; R & D, Minneapolis, Minnesota, USA). The
minimum detectable level of this assay was 0.5 pg/ml. The
reproducibility of IL10 assays was confirmed by interlabora-
tory examination of seven selected tracheal fluid specimens
(Airways Research Centre, John Hunter Hospital, Newcastle,
Australia), as well as by the addition of anti-IL10 immu-
noglobulin and exogenous human IL10 to several selected
specimens. Cytokine values were expressed as weight/volume
of lavage because no other satisfactory correction factor for
tracheal fluid cytokine measurement is currently available.14
Statistical analysis
This was performed with the Mann-Whitney U, Kruskal-
Wallis, Student’s t, and Fisher exact tests. p < 0.05 was
considered significant.
RESULTS
Of the 52 ventilated infants enrolled into our study, two died
from necrotising enterocolitis before 36 weeks corrected age,
and their results were excluded from our final analysis. Thirty
one of the remaining 50 infants were preterm—that is, < 37
weeks gestation. Most (23/31, 74%) were ventilated for HMD.
Table 1 summarises the clinical characteristics of all 50
infants. All HMD infants received at least one dose of
exogenous bovine surfactant. None of the infants received
corticosteroids during the first week even thoughmost infants
with CLD (8/11, 73%) and a term girl with MAS were treated
with dexamethasone during or after the second week of life.
Two mothers had chorioamnionitis and both their infants
developed CLD. Placental bacterial cultures were sterile in one
and positive for group B streptococcus in the other. In our insti-
tution, low vaginal swabs are routinely performed on gravid
women either at 28 weeks gestation or at delivery (if birth
occurred before 28 weeks). Group B streptococcus was grown in
the low vaginal swabs of four women (three with infants with
CLD, and one with a term infant), and these women were
treated with intrapartum penicillin.None of their infants devel-
oped positive blood cultures. A non-CLD preterm infant grew
Enterococcus coli on blood collected immediately after birth. Her
mother’s low vaginal swab was negative.
The 11 (36%) preterm infants who developed CLD were sig-
nificantly more premature than the 20 preterm infants whose
acute lung disease resolved, and the duration of ventilation
was significantly longer (table 1). Two 28 week preterm
infants without CLD were re-intubated at 52 and 21 days of
age because of bronchiolitis and coagulase negative staphylo-
coccus sepsis respectively. These infants were not oxygen
dependent and both were easily extubated (into room air)
after resolution of the acute illnesses.
None of the infants in our study were treated with dexam-
ethasone during the time of specimen collection. Six infants
(three with CLD and three without) were given theophylline
before extubation, but no specimens were obtained from
infants on concurrent theophylline treatment.
Of the 112 tracheal fluid specimens obtained, 12 (four from
each group) were discarded because of low aspirate volume
(less than 50 µL). Median tracheal fluid volume was 100 µL
(range 50–100) for CLD specimens, 110 µL (range 50–450) for
non-CLD preterm specimens, and 150 µL (range 50–400) for
term specimens. Cytokine and cell analysis were thus
performed on 100 tracheal fluid samples (20 CLD, 44 non-CLD
preterm, 36 term).
Tracheal fluid leucocytes in relation to CLD
There was a wide range of white cells in the tracheal fluid from
all three groups. Median cell count was lowest in non-CLD
preterm infants and highest in term infants, but overall values
were not significantly different (median (range) white cell
count: CLD, 4.3 × 106 cells/ml (0.15–15.8); non-CLD preterm,
2.9 × 106 cells/ml (0–107); term, 7.6 × 106 cells/ml (0–116.2),
p = 0.771). A term female infant with MAS on day 2 (116.3 ×
106 cells/ml), a 28 week female infant with transient
tachypnoea of the newborn on day 1 (85.3 × 106cells/ml), and
a 32 week male infant with HMD on day 7 (107 × 106 cells/ml)
had the highest tracheal fluid white cell counts. The 32 week
boy was extubated on day 8, the 28 week girl on day 2, and the
term infant on day 11. None of them were treated with
steroids and none developed CLD.
Neutrophils were the predominant leucocytes in tracheal
fluid. Non-CLD preterm infants had the lowest proportion of
neutrophils (mean (SD) 66.4 (41.8)%). Term infants had the
highest (85.8 (24.6)%, p = 0.018). Infants with CLD had
intermediate numbers of neutrophils (70.9 (31.3)%), but this
was not significantly different from the other two groups
(p = 0.712 v non-CLD preterm; p = 0.11 v term).
Neutrophil apoptosis in relation to CLD and postnatal
age
Overall, term infants had a higher percentage of apoptotic
neutrophils in week 1 (median 0.5%, range 0–10.5%)
compared with either CLD (median 0.22%, range 0–1.3%;
Figure 1 Neutrophil showing the characteristic changes of
apoptosis (arrow) with densely condensed and rounded nuclear
material.
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p = 0.046) or the combination of all preterm infants (median
0.26%, range 0–1.5%; p = 0.019). The highest (10.5%) was
from a female infant with MAS from tracheal fluid specimens
obtained on day 5. Figure 2 summarises the results.
As most of the infants without CLD were extubated after
the first 4 days of life, only a few tracheal fluid specimens were
obtained from these infants during this period. Tracheal fluid
results were thus divided into days 1–4 and 5–7 for compari-
son. Some infants had two tracheal fluid specimens in either
of the time epochs. To achieve equal weight for each infant in
this analysis, the mean value of these was taken as the single
individual value within the time epoch. Results remained
consistent with the trend illustrated in fig 2. Neutrophil apop-
tosis was either absent or less than 0.22% in the 11 infants
with CLD during the first 4 days of life (median 0%).
Compared with infants without CLD during the first 4 days,
those with CLD had a lower percentage of apoptotic
neutrophils (non-CLD preterm:median 0.47%, range 0–1.25%,
p = 0.001, Mann-Whitney; term infants: median 0.5%, range
0–3.25%, p = 0.018). There was a trend towards an increase in
the percentage of neutrophil apoptosis in infants with CLD
during days 5–7 (median 0.44%, range 0–1.3%, p = 0.046).
Median apoptosis on days 5–7 for non-CLD preterm and term
infants was 0.26% and 2.78% respectively, but differences did
not reach significance.
Neutrophil apoptosis in relation to IL10
IL10 concentration was less than 5 pg/ml in all CLD tracheal
fluid specimens (fig 3). The range of IL10 from the non-CLD
preterm specimens was much wider (0–938 pg/ml) and
fluctuated throughout the first week of life. IL10 levels were
greater than 5 pg/ml in 11 non-CLD preterm infants and in six
term infants. Respiratory conditions in this group of infants
were varied and ranged from those necessitating profound
ventilatory support (such as term infants with MAS) to those
with only mild disease (such as transient tachypnoea of the
newborn) or no lung disease (such as infants intubated elec-
tively for seizure control).
The relation between IL10 and apoptosis was examined in
non-CLD preterm and term infants because IL10 and neutro-
phil apoptosis levels were both low in infants with CLD. There
was no apparent correlation between IL10 and apoptosis in
either preterm (r = 0.128, p = 0.357, NS) or term (r = 0.212,
p = 0.331, ns) infants.
DISCUSSION
To our knowledge, our study is the first to examine both
reduced neutrophil apoptosis and IL10 in the tracheal fluid of
premature infants who subsequently develop CLD. IL10 inhib-
its the production of proinflammatory cytokines such as IL8,
tumour necrosis factor (TNF)α, and IL6 from neutrophils and
macrophages.15 16 These cytokines are essential for maintain-
ing inflammation. IL8, for example, is a powerful pulmonary
neutrophil chemotaxin that acts in concert with TNFα to pro-
long neutrophil longevity by inhibiting apoptosis.17 18 In a
recent pilot study, we found no difference in tracheal fluid IL8
between infants with and without CLD, although IL8 tended
to decrease towards the end of the first week in infants with-
out CLD.19 There is, as yet, little evidence that neutrophils
entering the lung as a result of injury are able to return to the
microcirculation after dissipation of the injurious process.3
Therefore, for healing to occur, redundant neutrophils need to
be inactivated and cleared from the lung.




Gestational age (weeks)* 27 (24–31) 31 (27–33) 40 (38–42)
Birth weight (g)* 813 (520–1500) 1600 (830–2190) 3640 (2220–4440)
Male 9 (82%) 14/20 (70%) 11/19 (58%)
Days ventilated* 30 (4–90) 5.5 (2–10) 5 (2–11)
Indications for ventilation
HMD 9 14 5
TTN 1 4 2
Apnoea 1 2
Meconium aspiration 0 0 3
PPHN 0 0 3
Myocarditis 0 0 1
CHD 0 0 1
HIE 0 0 3
Sepsis 0 0 1
Values are median (range) or number (%).
*p<0.001, Kruskal-Wallis.
CLD, Chronic lung disease; HMD, hyaline membrane disease; TTN, transient tachypnoea of the newborn;
PPHN, persistent pulmonary hypertension; CHD, congenital heart disease; HIE, hypoxic ischaemic
encephalopathy.
Figure 2 Percentage of neutrophils that are apoptotic in tracheal
fluids of ventilated infants during the first week of life. Three groups
of infants are shown: preterm infants with chronic lung disease
(CLD), preterm infants without CLD, and term infants. Fewer tracheal
fluid specimens were obtained beyond the first 4 days of life in
non-CLD preterm and term infants (closed circles).
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Apoptotic neutrophils lose the ability to degranulate poten-
tially injurious intracellular contents.20 Macrophages that
phagocytose apoptotic neutrophils do not release proinflam-
matory agents such as IL8, IL1β, and TNFα.21 22 Neutrophil
apoptosis is thus an important mechanism by which various
forms of acute lung injury are resolved.9 23 In this study, we
hypothesised that premature infants were more susceptible to
disordered lung healing because of reduced neutrophil apop-
tosis. Grigg et al7 noted apoptotic neutrophils at single time
points in the lungs of eight mechanically ventilated infants.
Their results, however, did not correlate with pulmonary out-
come. We examined ventilated infants on multiple occasions
over the first week of life and showed that the percentage of
apoptotic neutrophils in tracheal fluid did not increase above
0.25% of the total neutrophil count until after the fourth day
of life in infants with CLD. Our results suggest that this rela-
tive delay may expose vulnerable infants to continued neutro-
phil mediated lung injury.5 Periods of specimen analysis and
collection were divided into two periods of the first week of
life—that is, days 1–4 and days 5–7—because fewer tracheal
fluid specimens were collected after the first 4 days of life in
non-CLD preterm and term infants and because analysis of
neutrophil counts in the later part of the week would have
allowed us to capture the persistent pulmonary neutrophilia
characteristic of developing CLD.24
IL10 is currently the only known endogenous factor that
promotes neutrophil apoptosis.9 Exogenous IL10 attenuates
pulmonary inflammation in experimental animals by acceler-
ating neutrophil apoptosis and decreasing neutrophil
influx.9 25 Various forms of chronic and severe pulmonary
inflammatory disorders are associated with low levels of IL10,
including cystic fibrosis, asthma, and fatal acute respiratory
distress syndromes.26–28 IL10 levels are also reduced early in life
in infants who develop CLD of prematurity.29 30 McColm et al12
studied 11 infants less than 30 weeks gestation, nine of whom
developed CLD. Detectable IL10 was found in 57% of the tra-
cheal fluid specimens regardless of subsequent CLD develop-
ment. However, only two infants without CLD were studied,
and higher gestation infants were not studied by their
particular laboratory methods for comparison.We have shown
(in a concurrent study) that, although IL10 is predominantly
governed by gestation, more mature infants who were not
expected to develop CLD also had minimal IL10 in their lung
fluid. For example, a 29 week male infant needing only mini-
mal ventilation for apnoea and a 31 week male infant with
mild HMD had neither IL10 or apoptotic neutrophils in any of
their week 1 tracheal fluid specimens. Nevertheless, higher
levels of IL10 produced by more mature infants may have
contributed to lung healing by constraining neutrophil activ-
ity, as evidenced by increased levels of apoptosis. This study,
however, failed to show a positive correlation between IL10
and neutrophil apoptosis.
Other cytokines, however, also significantly influence
neutrophil longevity, and it is difficult to determine from our
study whether a causal relation exists between endogenous
IL10 and neutrophil apoptosis. Proinflammatory cytokines
such as IL8 and IL6 retard neutrophil apoptosis and are also
increased in the lung fluid of CLD prone infants.17 32–34 There
were also infants in our study who did not develop CLD
despite having neither high levels of IL10 nor apoptotic
neutrophils. Most of these infants, nevertheless, were more
mature, and the pulmonary protective value of IL10 may be
only significant in the most at risk—that is, the extremely
preterm population.
The peak frequency of neutrophil apoptosis occurs 6–72
hours after pulmonary injury,3 and previous observations have
shown that neutrophil apoptosis and subsequent phagocyto-
sis by primed macrophages is a rapid process; neither
neutrophils nor their cytoplasmic contents are recognisable as
soon as 30 minutes after engulfment.6 Optimal in vitro identi-
fication of neutrophil apoptosis in our study may have been
limited by various clinical constraints (such as laboratory
availability and tracheal suction timing). Non-CLD specimens
in our study were less complete than CLD specimens because
most of these infants had been extubated by the end of the
week. Therefore, we do not have a complete profile of infants
without CLD throughout the first week, and IL10 and neutro-
phil apoptosis may have been evident in these infants if sam-
pling times had differed. Even so, our findings describe a novel
lack of neutrophil apoptosis and IL10 in CLD specimens com-
pared with non-CLD specimens during the first 4 days of life.
We identified neutrophil apoptosis by light microscopy in a
similar fashion to Savill et al6 by noting shrinkage of the entire
neutrophil and condensation of the nuclear chromatin into a
rounded lobe. We also observed some atypical clump-like
changes suggested by Ishii et al8 to be representative of an early
part of the apoptotic process.
Exogenous factors such as commonly used medications
may modulate the rate of neutrophil apoptosis.
Erythromycin35 and theophylline36 accelerate, whereas gluco-
corticoids retard,37 neutrophil apoptosis. The anti-
inflammatory properties of glucocorticoids are well known.
Despite retarding neutrophil apoptosis, glucocorticoids pro-
mote macrophage phagocytosis of apoptotic white cells.38
However, none of the infants in our study were treated with
glucocorticoids during week 1, and most of the infants with-
out CLD (term and preterm) did not receive theophylline until
immediately before extubation. We therefore cannot conclude
that the difference in the frequency of apoptosis between the
groups of infants in our study was influenced in any way by
theophylline or glucocorticoids. Further study is needed to
assess the effect that these medications have on early pulmo-
nary inflammation in susceptible preterm infants.
In conclusion, our results show that neutrophil apoptosis
increases with gestational maturity and that infants who sub-
sequently developed CLD had negligible amounts of apoptosis
and IL10. However, the interplay of factors controlling pulmo-
nary inflammation is complex and probably not dominated by
any one cytokine. IL10 has anti-inflammatory properties that
Figure 3 Interleukin 10 (IL10) in tracheal fluids of ventilated infants
during the first week of life. IL10 concentrations are shown in log10
scale. Three groups of infants are shown: preterm infants with CLD,
preterm without CLD, and term infants. Fewer tracheal fluid
specimens were obtained beyond the first 4 days of life in non-CLD
preterm and term infants (closed circles).
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may have the potential to mitigate the neutrophil mediated
disorganised pulmonary healing and repair characteristic of
CLD. Our study supports the observation of Jones et al29 show-
ing low IL10 in tracheal fluid in CLD prone infants. As gluco-
corticoids, with all their numerous side effects, are the only
current relatively beneficial treatment for CLD, further inves-
tigation into ways of modulating the inflammatory profile of
the preterm lung with novel anti-inflammatory treatments
during the first week of life may eventually help to prevent
and treat CLD.
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